MHRA Cites Data Management and Integrity Issues in GCP Inspection Report

Drug Industry Daily
A A
Problems with inaccessible trial master files and confusing questionnaires are among the nonconforming practices cited in the latest GCP inspection report from the UK Medicines and Healthcare Products.

To View This Article:

Login

Subscribe To Drug Industry Daily